These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2184466)

  • 1. Human risk assessment of carcinogens from an administrative perspective.
    Tesseraux I; Lommel A; Ollroge I; Kappos AD; Koss G
    Regul Toxicol Pharmacol; 1990 Feb; 11(1):63-7. PubMed ID: 2184466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of human data in quantitative risk assessment of carcinogens: impact on epidemiologic practice and the regulatory process.
    Shore RE; Iyer V; Altshuler B; Pasternack BS
    Regul Toxicol Pharmacol; 1992 Apr; 15(2 Pt 1):180-221. PubMed ID: 1626069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The calculation and use of carcinogenic potency: a review.
    Barr JT
    Regul Toxicol Pharmacol; 1985 Dec; 5(4):432-59. PubMed ID: 3912853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of animal data in human cancer risk assessment.
    Meijers JM; Swaen GM; Bloemen LJ
    Regul Toxicol Pharmacol; 1997 Apr; 25(2):94-102. PubMed ID: 9185886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of quantitative structure-activity relationship (QSAR) models to predict the carcinogenic potency of chemicals. II. Using oral slope factor as a measure of carcinogenic potency.
    Wang NC; Venkatapathy R; Bruce RM; Moudgal C
    Regul Toxicol Pharmacol; 2011 Mar; 59(2):215-26. PubMed ID: 20951756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International cancer risk assessment: the impact of biologic mechanisms.
    Whysner J; Williams GM
    Regul Toxicol Pharmacol; 1992 Feb; 15(1):41-50. PubMed ID: 1553411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative factors in chemical carcinogenesis: variation in carcinogenic potency.
    Krewski D; Szyszkowicz M; Rosenkranz H
    Regul Toxicol Pharmacol; 1990 Aug; 12(1):13-29. PubMed ID: 2217915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scientific analysis of the proposed uses of the T25 dose descriptor in chemical carcinogen regulation.
    Roberts RA; Crump KS; Lutz WK; Wiegand HJ; Williams GM; Harrison PT; Purchase IF
    Arch Toxicol; 2001 Nov; 75(9):507-12. PubMed ID: 11760810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Availability of epidemiologic data for chemicals known to cause cancer in animals: an update.
    Karstadt M
    Am J Ind Med; 1998 Nov; 34(5):519-25. PubMed ID: 9787859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The problem of extrapolating from observed carcinogenic effects to estimates of risk for exposed populations.
    Saffiotti U
    J Toxicol Environ Health; 1980; 6(5-6):1309-26. PubMed ID: 7463522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
    McClellan RO
    Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk assessment of carcinogens in food.
    Barlow S; Schlatter J
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):180-90. PubMed ID: 19909764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summary of carcinogenic potency and positivity for 492 rodent carcinogens in the carcinogenic potency database.
    Gold LS; Slone TH; Bernstein L
    Environ Health Perspect; 1989 Feb; 79():259-72. PubMed ID: 2707207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of carcinogen hazard characterisation based on animal studies and epidemiology.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):66-70. PubMed ID: 15667598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans.
    Osimitz TG; Droege W; Boobis AR; Lake BG
    Food Chem Toxicol; 2013 Oct; 60():550-62. PubMed ID: 23954551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What do animal cancer tests tell us about human cancer risk?: Overview of analyses of the carcinogenic potency database.
    Gold LS; Slone TH; Ames BN
    Drug Metab Rev; 1998 May; 30(2):359-404. PubMed ID: 9606609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of 'secondary mechanism' in the regulation of carcinogens; a chronology.
    Scheuplein RJ
    Cancer Lett; 1995 Jun; 93(1):103-12. PubMed ID: 7600537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk assessment of carcinogens in food with special consideration of non-genotoxic carcinogens. Scientific arguments for use of risk assessment and for changing the Delaney Clause specifically.
    Williams GM; Karbe E; Fenner-Crisp P; Iatropoulos MJ; Weisburger JH
    Exp Toxicol Pathol; 1996 Feb; 48(2-3):209-15. PubMed ID: 8672879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for cancer.
    Lyman GH
    Prim Care; 1992 Sep; 19(3):465-79. PubMed ID: 1410059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.